Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial

DSpace Repository

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial

Author: Hoster, Eva; Delfau-Larue, Marie-Helene; Macintyre, Elizabeth; Jiang, Linmiao; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles; Thieblemont, Catherine; Tilly, Herve; Wirths, Stefan; Feugier, Pierre; Huebel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C.; Dreyling, Martin; Pott, Christiane
Tübinger Autor(en):
Wirths, Stefan
Published in: Journal of Clinical Oncology (2024), Bd. 42, H. 5, S. 538-549
Verlagsangabe: Philadelphia : Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1200/JCO.23.00899
ISSN: 0732-183X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)